NEWSOARA
Newsoara is a biomedical technology developer that specializes in the development of medical devices.
NEWSOARA
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2018-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Total Funding:
29.04 M USD
Similar Organizations
Sensome
Sensome offers micro-sensor technology to turn medical devices into connected healthcare devices.
Lansion Biotechnology
Lansion Biotechnology is specialized in research & development, production, sell, services of in vitro diagnostic reagents and devices.
SceneRay
SceneRay is a medical device company dedicated to the design, Development, and distribution of neuromodulation devices.
Shanghai Horizon Medical Technology
Shanghai Horizon Medical Technology focuses on medical solutions.
Shanghai Kindly Medical Instruments
Shanghai Kindly Medical Instruments focuses on research, development, and sales of interventional medical devices.
Current Employees Featured
Benny Li Founder & CEO @ Newsoara
Founder & CEO
Yaner Cheer Fu Chief Financial Officer @ Newsoara
Chief Financial Officer
2020-09-01
Founder
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Newsoara
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Newsoara
More informations about "Newsoara"
Newsoara - Crunchbase Company Profile & Funding
Newsoara is a biomedical technology developer that specializes in the development of medical devices. Where is Newsoara's headquarters? Newsoara is located in Shanghai, Shanghai, …See details»
Genelux and Newsoara Announce Collaboration and License …
Sep 28, 2021 · Newsoara is a clinical-stage biopharmaceutical company with the mission to develop and commercialize life changing medicines for the treatment of patients with cancer, …See details»
Genelux and Newsoara Announce Collaboration and License …
Sep 28, 2021 · WESTLAKE VILLAGE, Calif., Sept. 28, 2021 /PRNewswire/ -- Genelux Corporation, a clinical-stage immunotherapy company, and Newsoara BioPharma Co., Ltd., …See details»
Newsoara - Funding, Financials, Valuation & Investors - Crunchbase
Newsoara is a biomedical technology developer that specializes in the development of medical devices.See details»
Zenith and Newsoara Biopharma Announce Expanded Licensing …
Nov 15, 2021 · Newsoara is a biotech company based in Shanghai, China with research laboratories in the Suzhou BioBAY focusing on novel drug research and development to …See details»
AUM Biosciences and Newsoara Biopharma Announce …
Nov 18, 2020 · Newsoara will be responsible for all development and commercialisation and will contribute for potential R&D funding for current and future investigational compounds in greater China. AUM and...See details»
Newsoara - Contacts, Employees, Board Members, Advisors
Newsoara is a biomedical technology developer that specializes in the development of medical devices.See details»
Palisade Bio and Newsoara Receive NMPA Clearance to …
May 5, 2022 · Newsoara Biopharma is a biotech company based in Shanghai, China with research laboratories in the Suzhou BioBAY focusing on novel drug research and …See details»
Zenith and Newsoara Biopharma Announce Expanded Licensing …
Nov 15, 2021 · Newsoara is a biotech company based in Shanghai, China with research laboratories in the Suzhou BioBAY focusing on novel drug research and development to …See details»
Zenith Epigenetics and Newsoara Announce Initiation of a …
CALGARY, Alberta, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”) and Newsoara BioPharma Co., Ltd. (“Newsoara”) announced today the …See details»
Palisade Bio and Newsoara Receive NMPA Clearance to …
May 5, 2022 · Newsoara Biopharma is a biotech company based in Shanghai, China with research laboratories in the Suzhou BioBAY focusing on novel drug research and …See details»
Genelux and Newsoara Announce Collaboration and ... - Markets …
Sep 28, 2021 · WESTLAKE VILLAGE, Calif., Sept. 28, 2021 /PRNewswire/ -- Genelux Corporation, a clinical-stage immunotherapy company, and Newsoara BioPharma Co., Ltd., …See details»
TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia
On March 2nd, 2019, TaiwanJ announced that its JKB-122, an effective phase 2 nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) drug candidate, had been …See details»
Zenith Epigenetics and Newsoara Announce Initiation of a
Sep 21, 2021 · Newsoara is a biotech company based in Shanghai, China with research laboratories in the Suzhou BioBAY focusing on novel drug research and development to …See details»
Zenith and Newsoara Biopharma Announce Expanded Licensing …
Nov 15, 2021 · Under the terms of the agreement, Newsoara will have the rights to develop, market, and distribute ZEN-3694 for all indications in the Territories. Zenith will receive an …See details»
Newsoara Forms $135 Million Novel Drug Deal with AUM Bio
Nov 18, 2020 · Shanghai Newsoara Biopharma announced a 5-year strategic partnership with Singapore's AUM Biosciences to co-develop up to six oncology drugs in China. Newsoara …See details»
Palisade Bio Announces Enrollment of First Patient in Newsoara …
Apr 5, 2023 · Carlsbad, CA and Shanghai, China, April 05, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical …See details»
Palisade Bio and Newsoara Announce Positive Topline
Jul 29, 2021 · Based on the beneficial clinical outcomes and good safety profile observed to date in phase 2 trials in both CV surgery and GI surgery, Palisade Bio and Newsoara plan to …See details»
Zenith Epigenetics and Newsoara Announce Initiation of a …
Sep 21, 2021 · Newsoara is a biotech company based in Shanghai, China with research laboratories in the Suzhou BioBAY focusing on novel drug research and development to …See details»
Palisade Bio and Newsoara Announce Positive Topline Efficacy …
Jul 29, 2021 · CARLSBAD, Calif. and SHANGHAI, China, July 29, 2021 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) and co-development partner Newsoara today announced …See details»